Header Logo

Connection

CHARLES F LEVENBACK to ErbB Receptors

Back to Details
This is a "connection" page, showing publications CHARLES F LEVENBACK has written about ErbB Receptors.
CHARLES F LEVENBACK
Connection Strength
0.025
ErbB Receptors
  1. Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer. Int J Gynecol Cancer. 2020 11; 30(11):1768-1774.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.